As quality control labs move toward more connected, data-driven operations, digital technologies must be adopted in a way that upholds patient safety.
Michael Levy
Advertisement
Michael Levy, MSc, MBA is senior vice president, Digital & Innovation, US Pharmacopeia (USP).
Articles by Michael Levy
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Regeneron's Libtayo Earns CHMP Nod for Expanded EU Dosing
2
Roche, Hansoh Sign Second ADC Pact Covering Preclinical and Roche-Selected Targets
3
Biomarker Testing Gaps Can Stall Targeted Oncology Therapy, BMS’s Dr Pennell Says
4
The BioPharm Brief: New Approval, Pediatric Progress, and Durable Remission
5